Xbrane Biopharma AB (XBRANE) — Defensive Interval Ratio

Latest as of June 2026: 351 days

Xbrane Biopharma AB (XBRANE) has a Defensive Interval Ratio of 351 days as of June 2026. Defensive assets of Skr96.82 Million (cash Skr-, short-term investments Skr-, receivables Skr96.82 Million) cover 351 days of daily cash needs of Skr276.15K/day.

Defensive Interval Ratio

351 days
Days of operational coverage

Defensive Assets

Skr96.82 Million
Cash + ST Investments + Receivables

Daily Cash Need

Skr276.15K
Current Liabilities ÷ 365

Current Liabilities

Skr100.79 Million
SEK

Xbrane Biopharma AB Defensive Interval Ratio (2012–2025)

This chart shows how Xbrane Biopharma AB's Defensive Interval Ratio has evolved across 13 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 351 days, meaning defensive assets of Skr96.82 Million can fund 351 days of operations without new revenue. For the complete balance sheet picture, see Xbrane Biopharma AB assets under control.

Annual Defensive Interval Ratio for Xbrane Biopharma AB (2012–2025)

The table below presents the year-by-year Defensive Interval Ratio for Xbrane Biopharma AB from 2012 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital to net assets of Xbrane Biopharma AB to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (SEK) Daily Cash Need Cash ST Investments Change (days)
2025 85 days Skr12.30 Million Skr144.28K/day Skr- Skr- ▼ -73 days
2024 158 days Skr232.68 Million Skr1.47 Million/day Skr- Skr- ▲ +78 days
2023 80 days Skr71.18 Million Skr894.68K/day Skr- Skr- ▲ +6 days
2022 73 days Skr47.46 Million Skr648.13K/day Skr- Skr- ▼ -10 days
2021 84 days Skr50.25 Million Skr601.83K/day Skr- Skr- ▼ -29 days
2020 113 days Skr58.37 Million Skr517.79K/day Skr- Skr- ▲ +97 days
2019 15 days Skr5.89 Million Skr382.51K/day Skr- Skr- ▼ -32 days
2018 47 days Skr20.92 Million Skr442.14K/day Skr- Skr- ▼ -117 days
2017 165 days Skr8.07 Million Skr49.02K/day Skr- Skr- ▼ -2196 days
2016 2360 days Skr38.05 Million Skr16.12K/day Skr31.34 Million Skr- ▲ +2330 days
2015 30 days Skr1.93 Million Skr64.12K/day Skr- Skr- ▼ -247 days
2014 277 days Skr296.57K Skr1.07K/day Skr- Skr- ▲ +107 days
2012 170 days Skr265.60K Skr1.56K/day Skr- Skr- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)